| Mineral absorption |
2.41 |
0.00e+0 |
48/60 (80%) |
MT1E;MT1F;MT1X;...
|
| Steroid biosynthesis |
2.01 |
5.36e-3 |
19/20 (95%) |
MSMO1;CYP51A1;SQLE;...
|
| Peroxisome |
1.91 |
2.15e-2 |
72/82 (87.8%) |
PRDX1;AMACR;ACOX2;...
|
| Propanoate metabolism |
1.86 |
2.15e-2 |
30/34 (88.24%) |
ABAT;ACAT2;DLD;...
|
| Renin secretion |
1.86 |
1.72e-2 |
61/69 (88.41%) |
AQP1;GNAI1;GNAS;...
|
| Terpenoid backbone biosynthesis |
1.86 |
1.61e-2 |
18/22 (81.82%) |
HMGCS2;ACAT2;HMGCS1;...
|
| Tryptophan metabolism |
1.75 |
3.83e-2 |
35/42 (83.33%) |
AOC1;ALDH8A1;ACAT2;...
|
| Proximal tubule bicarbonate reclamation |
1.74 |
3.89e-2 |
21/23 (91.3%) |
AQP1;PCK1;GLUD1;...
|
| Valine, leucine and isoleucine degradation |
1.73 |
3.93e-2 |
42/48 (87.5%) |
HMGCS2;ABAT;ACAT2;...
|
| Synthesis and degradation of ketone bodies |
1.73 |
3.65e-2 |
9/10 (90%) |
HMGCS2;ACAT2;HMGCS1;...
|
| Citrate cycle (TCA cycle) |
1.70 |
4.49e-2 |
30/30 (100%) |
PCK1;DLST;DLD;...
|
| Steroid hormone biosynthesis |
1.70 |
4.56e-2 |
43/61 (70.49%) |
AKR1C3;CYP1B1;HSD17B7;...
|
| Glycine, serine and threonine metabolism |
1.69 |
4.54e-2 |
31/40 (77.5%) |
PGAM1;GATM;DLD;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.67 |
4.75e-2 |
49/77 (63.64%) |
CYP1B1;GSTT2;GSTP1;...
|
| Ovarian steroidogenesis |
1.67 |
4.72e-2 |
41/51 (80.39%) |
GNAS;AKR1C3;CYP1B1;...
|
| Cell adhesion molecules |
-1.68 |
3.15e-2 |
118/148 (79.73%) |
CADM1;HLA-DOB;HLA-DOA;...
|
| Type I diabetes mellitus |
-1.71 |
2.90e-2 |
38/43 (88.37%) |
HLA-DRA;HLA-DRB1;GZMB;...
|
| Intestinal immune network for IgA production |
-1.76 |
1.46e-2 |
38/48 (79.17%) |
TGFB1;ITGA4;HLA-DRA;...
|
| Leishmaniasis |
-1.78 |
1.09e-2 |
67/77 (87.01%) |
MARCKSL1;JAK2;C3;...
|
| Asthma |
-1.90 |
1.84e-3 |
25/31 (80.65%) |
HLA-DRA;HLA-DRB1;HLA-DPA1;...
|
| Systemic lupus erythematosus |
-1.94 |
1.02e-3 |
45/135 (33.33%) |
CD80;HLA-DOB;HLA-DOA;...
|
| Th1 and Th2 cell differentiation |
-1.95 |
1.15e-3 |
80/92 (86.96%) |
PLCG1;RBPJ;HLA-DOB;...
|
| Graft-versus-host disease |
-1.95 |
1.31e-3 |
32/42 (76.19%) |
KLRD1;HLA-DRA;HLA-DRB1;...
|
| Hematopoietic cell lineage |
-2.05 |
1.53e-3 |
90/99 (90.91%) |
HLA-DMB;ITGA2;CD4;...
|
| Th17 cell differentiation |
-2.06 |
0.00e+0 |
95/107 (88.79%) |
PLCG1;IL1R1;HLA-DOB;...
|
| Viral myocarditis |
-2.08 |
0.00e+0 |
53/60 (88.33%) |
CD80;HLA-DOB;HLA-DOA;...
|
| Allograft rejection |
-2.10 |
0.00e+0 |
32/38 (84.21%) |
HLA-DRA;HLA-DRB1;GZMB;...
|
| Primary immunodeficiency |
-2.11 |
0.00e+0 |
33/38 (86.84%) |
RAG2;TAP1;RFXANK;...
|
| Autoimmune thyroid disease |
-2.34 |
0.00e+0 |
46/53 (86.79%) |
HLA-DRA;HLA-DRB1;GZMB;...
|
